This announcement is a separate document:
信達生物：(1)與賽諾菲達成多項目戰略合作及許可協議；及(2)根據股份發行協議按一般授權向賽諾菲發行認購股份
INNOVENT BIO: (1) STRATEGIC MULTI-PROGRAM COLLABORATION AND LICENSE AGREEMENT ENTERED INTO WITH SANOFI; AND (2) ISSUE OF SUBSCRIPTION SHARES TO SANOFI UNDER GENERAL MANDATE PURSUANT TO SHARE ISSUANCE AGREEMENT
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.